MedTrace Logo

Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism

NCT06081881 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-12-01

No results posted yet for this study

Summary

to detect the incidence of CTEPH patients.

Primary outcome To predict CETHP in symptomatic patients after pulmonary embolism episode.

Secondary outcome:

On Echocardiography revealed RV dysfunction which are peak TR Velocity , the RV/LV basal diameter ratio, flattening of the IVS, RV acceleration time and/or midsystolic notching, IVC diameter with decreased inspiratory collapse and RA area.

Conditions

  • Chronic Thromboembolic Pulmonary Hypertension

Sponsors & Collaborators

  • Ester Ashraf Faried Beshay

    lead OTHER

Principal Investigators

  • Ester A Faried, Resident · Assiut University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2026-10-01
Completion
2026-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06081881 on ClinicalTrials.gov